factual

Bristol Myers Squibb Staffs Celgene Cell Therapy One-to-One

Bristol Myers Squibb bought Celgene, a pioneer in CAR T-cell therapy, and has roughly the same number of employees delivering these compounds as the number of patients being treated, around 4,000 each.

factualpending

Speaker

Alex

Evidence Quote

“they have the same amount of employees working on delivering these compounds as they have treated patients, so something like 4,000 each.”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...